In late November, some 50,000 representatives from the medical imaging industry will once again gather at McCormick Place in Chicago for RSNA 2018. Vendors will share their latest and greatest solutions, attendees will take part in fascinating sessions and the convention center will burst with enthusiasm, energy and excitement.

The idea of implementing a “deconstructed PACS”—using multiple vendors for key solutions such as your PACS, VNA and viewers—was gaining huge momentum among imaging providers as recently as a few years ago. Now, however, providers are moving away from a best-of-breed approach to its imaging solutions and embracing a single-source approach.

Women who are screened regularly for breast cancer have a much lower risk of dying from the disease within 20 years of diagnosis than women who do not undergo regular screening, according to new findings published in Cancer.

Many medical students think breakthroughs in artificial intelligence (AI) will reduce demand for radiologists, according to a new study published in Academic Radiology. AI has even discouraged some students from considering a career in radiology.

Children presenting with signs of appendicitis should receive careful further evaluation if the usual first-line exam, abdominal ultrasound, fails to deliver a clear view of the vestigial digestive-system organ.

The rise of high-deductible health plans (HDHPs) has led to patients worrying more about the high prices associated with imaging services than ever before. According to a new study published in the Journal of the American College of Radiology, this often exposes those patients to inaccurate information.

Convolutional neural networks (CNNs) trained with 20,000 labeled images can accurately classify chest x-rays as normal or abnormal, according to new findings published in Radiology. Training the CNN with an additional 180,000 images, the authors noted, only yielded “marginal” benefits.

Phone calls work better as patient reminders than mailed letters when attempting to increase compliance for cancer screening, according to a new study published in the Journal of the American Board of Family Medicine.

The University of Missouri Research Reactor (MURR) in Columbia has announced it is the first domestic supplier of Iodine-131 (I-131), a radioisotope used to diagnose and treat thyroid cancer and hyperthyroidism, in the last 30 years.